Fingerprint
Dive into the research topics of 'Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)
Thierry Jahan, Lin Gu, Robert Kratzke, Arkadiusz Dudek, Gregory A. Otterson, Xiaofei Wang, Mark Green, Everett E. Vokes, Hedy Lee Kindler
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations